ArticleCase reports in medicine2026
Fibrous Dysplasia Meets Intramuscular Myxoma: Mazabraud Syndrome-First Documented Case in Pakistan.
Article in Case reports in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fibrous Dysplasia Meets Intramuscular Myxoma: Mazabraud Syndrome-First Documented Case in Pakistan.Case reports in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mazabraud syndrome (MS) is a rare benign genetic disorder characterized by the coexistence of fibrous dysplasia (FD) and intramuscular myxoma (IM), with a very limited number of cases reported worldwide, and none has been documented in Pakistan until now. It typically presents in middle-aged females and affects the lower limbs. Its pathogenesis is associated with activating mutations in the GNAS gene. This disease is often under-recognized in low-income countries. It can rapidly progress to bone deformities, fractures, and unnecessary aggressive treatments if not promptly recognized. Case Presentation: A 64-year-old male presented with progressive fatigue and pallor for three months, alongside a lifelong history of multiple bone deformities and painless soft tissue swellings. He had recurrent fractures since childhood, leading to severe limb deformities and dependence on crutches. Physical exam revealed bosselated swellings over the axilla, thigh, and groin, with significant limb shortening. Imaging showed widespread lytic lesions and necrotic soft tissue masses. Blood work revealed hypochromic microcytic anemia with rouleaux formation; white cell and platelet counts were normal. Bone marrow biopsy demonstrated Grade III myelofibrosis with characteristic "Chinese letter" trabeculae, confirming FD. Biopsy of soft tissue masses showed benign IMs. A diagnosis of MS was made based on the coexistence of polyostotic FD and multiple myxomas. Conclusion: MS is a rare and benign genetic disorder that requires a high index of suspicion for timely diagnosis. This unique case underscores the need for increased clinical awareness of MS in resource-limited settings where genetic testing is not common and the importance of multidisciplinary evaluation for accurate diagnosis and management. Timely diagnosis and treatment can prevent bone deformities, fractures, and disabilities and improve patient outcomes for this uncommon syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.